Skip to main content
Clinical Trials/NCT02847572
NCT02847572
Completed
Not Applicable

A Clinical Assessment of Visual Performance of Combining the Tecnis Symfony Extended Range of Vision IOL (ZXR00) With the +3.25D Tecnis Multifocal 1-Piece IOL (ZLB00) in Subjects Undergoing Bilateral Cataract Extraction

Crystal Clear Vision1 site in 1 country50 target enrollmentJanuary 2016
ConditionsCataract

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cataract
Sponsor
Crystal Clear Vision
Enrollment
50
Locations
1
Primary Endpoint
Visual Acuity
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This will be a single center, non comparison clinical trial. Fifty study patients will have the Symfony IOL implanted in their dominant eye and a +3,25D Tecnis Multifocal in their non-dominant eye. The investigators will be evaluated vision at distance, intermediate and near as well as assessing patient satisfaction and spectacle independence.

Detailed Description

Each study patient will undergo the same routine cataract extraction procedure in each eye. In their dominant eye a Tecnis Symfony IOL will be implanted and in the non dominant eye, a Tecnis +3.25D Multifocal implanted. The surgeries will be within 2 days of each other. Every patient will receive same postoperative instructions and medications. The aim is to investigate the potential benefits of implanting two different IOL's to give the patient a wider range of near vision with decreased risk of haloing and glare to enable them to be less dependent on reading glasses

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
December 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Crystal Clear Vision
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • good general health,
  • willing to comply with study instructions,
  • Visual potential of 20/30 or better,
  • less than 1.5D of corneal astigmatism,
  • normal macula,
  • clear lens or cataract,
  • pupil size greater than 3.5mm

Exclusion Criteria

  • known pathology to affect visual outcome,
  • amblyopia or strabismus,
  • pupil abnormalities,
  • zonule problems,
  • keratoconus,
  • no prior ocular surgery,use of medication that could affect vision,
  • uncontrolled systemic disease

Outcomes

Primary Outcomes

Visual Acuity

Time Frame: 3 months

Vision will be measured at distance, intermediate and near with and without correction.

Secondary Outcomes

  • Patient Satisfaction(3 months)

Study Sites (1)

Loading locations...

Similar Trials